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Introduction & Objectives
• Excisional biopsy is the gold standard in diagnosis of
suspected lymphomas
• Core Needle Biopsy (CNB) offers an alternative
– Less expensive
– Non-invasive
– Fewer procedural risks
• We want to evaluate the accuracy of CNB at TJUH to
provide guidance for initial workup of suspected lymphoma

Objectives
& Hypothesis
• Research Question
– What is the diagnostic accuracy of excisional and
core needle biopsies at Thomas Jefferson
University Hospital?

• Hypothesis
– We expect CNB will be similar in diagnostic
ability to excisional biopsy in the diagnosis of
lymphomas.

Approach & Results
• Medical chart review of all suspected new diagnosis of
lymphomas at Thomas Jefferson University
• January 1st, 2016 to December 31st, 2019
• All CNB and Excisional biopsies in these patients will be reviewed
– Cases from outside hospitals referred to Jefferson were excluded

• Type of biopsy
–
–
–
–

Site
Additional CNB or excisional biopsies, if applicable
Final pathologic diagnosis
Ancillary studies used (immunohistochemistry, FISH, etc)

• Data obtained from Thomas Jefferson University pathology labs
• Adequacy and diagnostic odds ratio will be calculated for CNB
and excisional biopsies

Approach and Results
• 457 cases reviewed; 339 excisional and 118 CNB
– Excisional biopsy was adequate 97% of the time,
while CNB was adequate 58%
– CNB found to have a diagnostic odds ratio of
0.03583

• Inadequate CNB samples were found regardless
of needle size
• Most common CNB sites (axillary, inguinal,
supraclavicular) are easily accessible for excision

Conclusions
• Excisional biopsy should remain standard of care
for initial diagnosis of lymphoma
• Use of CNB has been increasing at Jefferson
from 19% in 2016 to 31.6% in 2018
– 27.7% in 2019

• We would like to find a way to reduce these
numbers

Future Directions
• A QI project is underway
• Goals:
– Understand the reasons for ordering CNB or
excisional biopsy
– Educate the key providers involved

• Variables being considered:
– Was surgery involved? Oncology?
– Inpatient vs Outpatient
– Suspected diagnosis prior to biopsy
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